Financial Health Check: Examining Inmode Ltd (INMD)’s Key Ratios

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

Inmode Ltd (NASDAQ: INMD) closed the day trading at $17.45 down -0.96% from the previous closing price of $17.62. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 0.95 million shares were traded. INMD stock price reached its highest trading level at $17.91 during the session, while it also had its lowest trading level at $17.44.

Ratios:

For a better understanding of INMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.69. For the most recent quarter (mrq), Quick Ratio is recorded 12.29 and its Current Ratio is at 13.18. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on November 03, 2023, Downgraded its rating to Neutral and sets its target price to $24 from $52 previously.

On October 13, 2023, Canaccord Genuity Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $55 to $22.

On March 29, 2023, UBS started tracking the stock assigning a Buy rating and target price of $40.UBS initiated its Buy rating on March 29, 2023, with a $40 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMD now has a Market Capitalization of 1476603392 and an Enterprise Value of 732905984. As of this moment, Inmode’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.56, and their Forward P/E ratio for the next fiscal year is 6.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.00 while its Price-to-Book (P/B) ratio in mrq is 1.86. Its current Enterprise Value per Revenue stands at 1.49 whereas that against EBITDA is 3.734.

Stock Price History:

Over the past 52 weeks, INMD has reached a high of $48.25, while it has fallen to a 52-week low of $17.29. The 50-Day Moving Average of the stock is -19.03%, while the 200-Day Moving Average is calculated to be -36.77%.

Shares Statistics:

Over the past 3-months, INMD traded about 1.61M shares per day on average, while over the past 10 days, INMD traded about 2025620 shares per day. A total of 83.98M shares are outstanding, with a floating share count of 76.38M. Insiders hold about 9.73% of the company’s shares, while institutions hold 63.25% stake in the company. Shares short for INMD as of 1711584000 were 5909444 with a Short Ratio of 3.67, compared to 1709164800 on 5752750. Therefore, it implies a Short% of Shares Outstanding of 5909444 and a Short% of Float of 7.4399999999999995.

Earnings Estimates

Investors are eagerly awaiting the insights provided by Mind Medicine (MindMed) Inc. analysts currently analyzing and rating the stock of Inmode Ltd (INMD).The consensus estimate for the next quarter is $17.45, with high estimates of $5.91 and low estimates of $8.43.

Analysts are recommending an EPS of between $Technology and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.

Most Popular

[the_ad id="945"]